Biotech Investment Analyst — Drug Asset & Company Assessment

HumanitApp

United States

Remote

USD 165,000 - 276,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Mercor is seeking a US-based biotech investment analyst with a specialist-fund background to create and critique rubrics for evaluating commercial drugs and drug-development programs.

The engagement is a paid pilot (10–20 hours over 1–2 weeks), remote, with potential for ongoing work and strong contributors. You will assess assets and company profiles end-to-end and flag weak or unsubstantiated assumptions.

Qualifications

  • US-based biotech/healthcare investment analyst with a specialist-fund background.
  • Familiarity with biotech/pharma development programs.
  • Able to assess a drug asset and the company behind it end-to-end.
  • 5+ years evaluating biotech/pharma companies or assets.

Responsibilities

  • Create and critique rubrics that analyze commercial drugs and drug-development programs.
  • Provide overall company and asset assessment mechanism, clinical data, competitive position, and value drivers.
  • Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions.
  • Apply your assessment across the pilot's set of companies (~5–10).

Skills

Biotech investment analysis
Specialist fund background
Biotech/pharma development
Asset assessment end-to-end

Job description

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work

creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.

  • Create and critique rubrics that analyze commercial drugs and drug-development programs.
  • Provide overall company and asset assessment mechanism, clinical data, competitive position, and value drivers.
  • Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions.
  • Apply your assessment across the pilot's set of companies (~5–10).
  • US-based biotech / healthcare investment analyst with a specialist-fund background.
  • Familiarity with biotech/pharma development programs.
  • Able to assess a drug asset and the company behind it end-to-end.
  • 5+ years evaluating biotech/pharma companies or assets.

Engagement Details: Duration: Approximately 10–20 hours over a 1–2 week pilot. Remote.

US-based.

Why Participate: Help improve expert AI evaluation of drugs and drug-development programs. Recurring engagement for strong contributors.

AI evaluation Clinical reasoning Research

Who this role may fit

This opportunity may suit professionals with relevant experience in AI evaluation, Clinical reasoning, Research. Review the official description and requirements before applying.

Compensation context

The listing states $120 - $200 / hour. Confirm the final rate, workload, and payment terms during the official application process.

  • You can show recent, specific work involving AI evaluation, Clinical reasoning, Research.
  • The listed commitment of 15 hours/week fits your schedule.
  • You can communicate your reasoning clearly in the application language.
  • You are comfortable with project availability and hours varying over time.
Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Biotech Investment Analyst — Drug Asset & Company Assessment
Biotech Investment Analyst — Drug Asset & Company Assessment

Confidential • United States

Remote
USD 83,000 - 152,000
Biotech Investment Analyst — Rubric & AI Evaluation
Biotech Investment Analyst — Rubric & AI Evaluation

HumanitApp • United States

Hybrid
USD 165,000 - 276,000
Biotech Investment Analyst — Drug Asset & Company Assessment
Biotech Investment Analyst — Drug Asset & Company Assessment

Mercor • United States

Remote
USD 165,000 - 276,000
Remote Biotech Investment Analyst — Drug Assets & Firms
Remote Biotech Investment Analyst — Drug Assets & Firms

Mercor • United States

Remote
USD 165,000 - 276,000
Biotech Investment Analyst — Drug Asset & Company Assessment
Biotech Investment Analyst — Drug Asset & Company Assessment

Auraone • United States

Remote
USD 165,000 - 276,000
Disease-Area Clinician — Trial Endpoints & Prescribing
Disease-Area Clinician — Trial Endpoints & Prescribing

Confidential • United States

Remote
USD 138,000 - 276,000
Disease-Area Clinician — Trial Endpoints & Prescribing
Disease-Area Clinician — Trial Endpoints & Prescribing

Mercor • United States

Remote
USD 207,000 - 317,000
Referral bonus up to $920
Weekly payments via Stripe or Wise
Biotech Investment Analyst: Drug Assets & Company View
Biotech Investment Analyst: Drug Assets & Company View

Confidential • United States

Remote
USD 83,000 - 152,000
Remote Part-Time Biotech Investment Analyst - Drug Assets
Remote Part-Time Biotech Investment Analyst - Drug Assets

Medcruit Limited • United States

Remote
USD 165,000 - 276,000
Pharma Commercial Forecasting Expert — Launch Curves
Pharma Commercial Forecasting Expert — Launch Curves

Mercor • United States

Remote
USD 179,000 - 289,000